Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-09-14
1992-05-19
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 10, 530317, A61K 3702, C07K 700
Patent
active
051149206
ABSTRACT:
New antibiotics designated BU-3292T A and B are provided which exhibit antimicrobial activity and also inhibit the growth of tumors in experimental animal systems. BU-3292T A is produced by fermentation of Elytrosporangium sp. nov. (ATCC 53784) while the BU-3292T B compound is obtained by oxidation of BU-3292T A.
REFERENCES:
Meienhofer "Synthesis of actinomycin . . . " J. Am. Chem. Soc. 92(12) 3771-3777 (1970).
Meienhofer et al "Structure-Activity . . . " in Structure activity Relationship . . . ed. D. Perlman, 1977, pp. 488-494.
Konishi Masataka
Nishiyama Yuji
Oki Toshikazu
Sugawara Koko
Tomita Koji
Bristol-Myers Squibb Co.
Chang Celia
Han William T.
Ivy C. Warren
LandOfFree
BU-3292T antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with BU-3292T antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BU-3292T antibiotics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2417549